$387.25
9.472.51%
Last update: Nov 6, 4:25 AM
BeOne Medicines Ltd
ONCNASDAQ
The average analyst price target for BeOne Medicines is $387.40, 4.5% below the current price. Of 16 analysts, 16 rate it Buy. Targets range from $311 to $459. The latest change came on Oct 8, 2026, when RBC Capital raised its price target on BeOne Medicines from $450 to $459 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months
